INS and metabolic disease: Finally, the study findings (which warrant confirmation in larger populations) add novel insights into the pathophysiological processes leading from fat accumulation to metabolic disease in humans and provide novel data on the genetic regulation of NT as a gastrointestinal peptide deeply implicated in insulin resistance and cardiovascular risk profiles.